NYSE:NSPR

Inspiremd Stock Insider Trading

Healthcare > Medical - Devices

Buy NSPR

*Your capital is at risk

$0.96

-0.0499 (-4.94%)

At Close: Jun 03, 2026

InspireMD Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 71.38. In total, the insiders bought 4.93M and sold 566.48K NSPR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	71.38
● Buy	4.93M shares
● Sell	566.48K shares
68% Buy Activity Moderate Negative Correlation
Sell Signal Low Confidence May 19, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 71.38. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 31, 2025 Buy	Options to purchase common stock (right to buy)	Cohen Raymond W Director	Director	23 330 Value: $65.1K
Jul 31, 2025 Buy	Options to purchase common stock (right to buy)	Cohen Raymond W Director	Director	23 330 Value: $65.1K
Jul 31, 2025 Buy	Common Stock	Cohen Raymond W Director	Director	0 Value: $0
Jul 30, 2025 Buy	Common Stock P-Purchase	Roubin Gary S Director	Director	41 322 Value: $100.0K
Jul 30, 2025 Buy	Common Stock P-Purchase	Kester Thomas J Director	Director	30 991 Value: $75.0K
Jul 30, 2025 Buy	Common Stock P-Purchase	Slosman Marvin CEO And President	CEO / President	10 330 Value: $25.0K
Jul 30, 2025 Buy	Common Stock P-Purchase	Stuka Paul Director	Director	20 661 Value: $50.0K
Jul 30, 2025 Buy	Common Stock P-Purchase	Stuka Paul Director	Director	20 661 Value: $50.0K
Jul 30, 2025 Buy	Common Stock P-Purchase	Slosman Marvin CEO And President	CEO / President	10 330 Value: $25.0K
Jul 30, 2025 Buy	Common Stock P-Purchase	Kester Thomas J Director	Director	30 991 Value: $75.0K
Jul 30, 2025 Buy	Common Stock P-Purchase	Roubin Gary S Director	Director	41 322 Value: $100.0K
Jul 11, 2025 Buy	Common Stock X-InTheMoney	Kester Thomas J Director	Director	30 624 Value: $42.3K
Jul 11, 2025 Sell	Series I Warrant (right to buy) X-InTheMoney	Kester Thomas J Director	Director	30 624 Value: $42.3K
Jul 11, 2025 Sell	Series I Warrant (right to buy) X-InTheMoney	Kester Thomas J Director	Director	30 624 Value: $42.3K
Jul 11, 2025 Buy	Common Stock X-InTheMoney	Kester Thomas J Director	Director	30 624 Value: $42.3K
Jul 01, 2025 Buy	Common Stock X-InTheMoney	Stuka Paul Director	Director	87 500 Value: $121.0K
Jul 01, 2025 Sell	Series I Warrant (right to buy) X-InTheMoney	Stuka Paul Director	Director	87 500 Value: $121.0K
Jul 01, 2025 Sell	Series I Warrant (right to buy) X-InTheMoney	Stuka Paul Director	Director	87 500 Value: $121.0K
Jul 01, 2025 Buy	Common Stock X-InTheMoney	Stuka Paul Director	Director	87 500 Value: $121.0K
Jun 29, 2025 Buy	Common Stock X-InTheMoney	Berman Michael Director	Director	61 248 Value: $84.7K
Jun 29, 2025 Sell	Series I Warrant (right to buy) X-InTheMoney	Berman Michael Director	Director	61 248 Value: $84.7K
Jun 29, 2025 Sell	Series I Warrant (right to buy) X-InTheMoney	Berman Michael Director	Director	61 248 Value: $84.7K
Jun 29, 2025 Buy	Common Stock X-InTheMoney	Berman Michael Director	Director	61 248 Value: $84.7K
Jun 25, 2025 Buy	Common Stock X-InTheMoney	Roubin Gary S Director	Director	30 624 Value: $42.3K
Jun 25, 2025 Sell	Series I Warrant (right to buy) X-InTheMoney	Roubin Gary S Director	Director	30 624 Value: $42.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT INSPIREMD INC

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, ...

Read Full Profile Here